OXYCODONE HCl 50 mg/1 mL MEDSURGE oxycodone hydrochloride 50 mg/1 mL solution for injection ampoule أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

oxycodone hcl 50 mg/1 ml medsurge oxycodone hydrochloride 50 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - oxycodone hydrochloride, quantity: 50 mg/ml - injection, solution - excipient ingredients: citric acid monohydrate; sodium chloride; hydrochloric acid; sodium hydroxide; sodium citrate dihydrate; water for injections - oxycodone hcl medsurge solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

GLATIRAMER ACETATE-TEVA glatiramer acetate 40 mg/1 mL solution for injection prefilled syringe أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

glatiramer acetate-teva glatiramer acetate 40 mg/1 ml solution for injection prefilled syringe

teva pharma australia pty ltd - glatiramer acetate, quantity: 40 mg - injection, solution - excipient ingredients: mannitol; water for injections - glatiramer acetate is indicated for the: 1- reduction of the frequency of relapses in patients with relapsing remitting multiple sclerosis. 2-treatment of patients with a single clinical event suggestive of multiple sclerosis and at least two clinically silent mri lesions characteristic of multiple sclerosis, if alternative diagnoses have been excluded.

OXYCODONE-HAMELN oxycodone hydrochloride 50 mg/1 mL injection solution ampoule أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

oxycodone-hameln oxycodone hydrochloride 50 mg/1 ml injection solution ampoule

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 50 mg - injection, solution - excipient ingredients: citric acid monohydrate; hydrochloric acid; sodium citrate dihydrate; water for injections; sodium hydroxide; sodium chloride - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE-HAMELN oxycodone hydrochloride 10 mg/1 mL injection solution ampoule أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

oxycodone-hameln oxycodone hydrochloride 10 mg/1 ml injection solution ampoule

hameln pharma pty ltd - oxycodone hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium hydroxide; sodium chloride; hydrochloric acid; water for injections; citric acid monohydrate - oxycodone-hameln solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

HYDROMORPHONE-HAMELN-HP hydromorphone hydrochloride 10 mg/1 mL solution for injection ampoule أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

hydromorphone-hameln-hp hydromorphone hydrochloride 10 mg/1 ml solution for injection ampoule

hameln pharma pty ltd - hydromorphone hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium chloride; hydrochloric acid; sodium citrate dihydrate; water for injections; sodium hydroxide - hydromorphone-hameln and hydromorphone-hameln-hp injections are indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

HYDROMORPHONE-HAMELN hydromorphone hydrochloride 2 mg/1 mL solution for injection ampoule أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

hydromorphone-hameln hydromorphone hydrochloride 2 mg/1 ml solution for injection ampoule

hameln pharma pty ltd - hydromorphone hydrochloride, quantity: 2 mg - injection, solution - excipient ingredients: water for injections; citric acid monohydrate; sodium citrate dihydrate; sodium hydroxide; hydrochloric acid; sodium chloride - hydromorphone-hameln and hydromorphone-hameln-hp injections are indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

HEMLIBRA emicizumab (rch) 30 mg/1 mL solution for injection vial أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

hemlibra emicizumab (rch) 30 mg/1 ml solution for injection vial

roche products pty ltd - emicizumab, quantity: 30 mg - injection, solution - excipient ingredients: arginine; water for injections; histidine; aspartic acid; poloxamer - hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in adult and paediatric patients with haemophilia a (congenital factor viii deficiency) with or without factor viii inhibitors.

BIMZELX bimekizumab 160 mg/1 mL solution for injection auto-injector أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

bimzelx bimekizumab 160 mg/1 ml solution for injection auto-injector

ucb australia pty ltd t/a ucb pharma division of ucb australia - bimekizumab, quantity: 160 mg/ml - injection - excipient ingredients: polysorbate 80; water for injections; glacial acetic acid; glycine; sodium acetate trihydrate - bimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.

Dormicum ® 5mg/1ml Injection الإمارات العربية المتحدة - الإنجليزية - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

dormicum ® 5mg/1ml injection

lunatus drug store llc france - 1ml ampoule x 10's - injection - 5mg/1ml - central nervous system-hypnotics , anxiolytics

OCTREOTIDE GH octreotide as acetate 500 micrograms/1 mL injection ampoule أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

octreotide gh octreotide as acetate 500 micrograms/1 ml injection ampoule

generic health pty ltd - octreotide, quantity: 500 microgram - injection, solution - excipient ingredients: glycine; mannitol; dilute hydrochloric acid; water for injections - for symptomatic control and reduction of growth hormone and igf-1 plasma levels in patients with acromegaly, including those who are inadequately controlled by surgery, radiotherapy, or dopamine agonist treatment. octreotide treatment is also indicated in acromegalic patients unfit or unwilling to undergo surgery, or in the interim period until radiotherapy becomes fully effective. for the relief of symptoms associated with the following functional tumours of the gastro-entero-pancreatic endocrine system: carcinoid tumours with features of the carcinoid syndrome; vasoactive intestinal peptide secreting tumours (vipomas). octreotide is not an antitumour therapy and is not curative in these patients. for reduction of the incidence of complications following pancreatic surgery.